Transwell Cell Migration Assay Using Human Breast Epithelial Cancer Cell

下载 PDF 引用 收藏 7 提问与回复 分享您的反馈 Cited by



Transwell migration assays have been widely used for studying the motility of different types of cells including metastatic cancer cells. The assay is also useful in screens for compounds that act as chemoattractants or inhibitors of chemotaxis for cells. The assay employs a permeable layer of support, usually a tissue-culture-treated microporous membrane, which is positioned between two compartments that mimic two different sets of microenvironments for cell survival/growth. Cells on one side of the membrane, when sensing chemoattractants placed on the other side of the compartment that diffuses through the membrane, can migrate through the pores in the membrane towards the source of the chemoattractants. Cells that migrate across the membrane can be quantified by fixing and counting. Human breast epithelial adenocarcinoma MD-231 cells grow relatively fast and are metastatic. The MB-231 cell line is used here to describe the procedures of an in vitro cell migration assay using the transwell apparatus.

Materials and Reagents

  1. Human MDA-MB-231 cell (ATCC, catalog number: HTB-26 ™)
  2. Dulbecco's modified eagle medium (DMEM) (Life Technologies, Invitrogen™, catalog number: 10313-021 )
  3. Fetal bovine serum (FBS) (ATCC, catalog number: 30-2020 ™)
  4. Trypsin-EDTA (Life Technologies, Invitrogen™, catalog number: 25200-056 )
  5. Trypsin inhibitor (soybean) (Life Technologies, Invitrogen™, catalog number: 17075-029 )
  6. Phosphate buffered saline (PBS) (Life Technologies, Invitrogen™, catalog number: 14190-144 )
  7. Collagen I (Sigma-Aldrich, catalog number: C7661 ) or Fibronectin (BD Biosciences, catalog number: 354008 )
  8. Glutaraldehyde (Sigma-Aldrich, catalog number: G6257 )
  9. Ethanol (Sigma-Aldrich, catalog number: 459836 )
  10. Crystal violet (Sigma-Aldrich, catalog number: C3886 )
  11. TCC-formulated Leibovitz's L-15 Medium (ATCC, catalog number: 30-2008 ™)


  1. Corning® Transwell® polycarbonate membrane inserts (Sigma-Aldrich, catalog number: CLS3421 ) or Millicell Cell Culture Inserts (EMD Millipore, catalog number: PI8P01250 )
  2. Cotton swabs
  3. Cell culture incubator: 37 °C and 5% CO2


  1. Carry MB-231 cells in DMEM with 10% FBS (use L-15 medium if needed).
  2. Wash cells twice with 1x PBS and trypsinize.
  3. Add 0.5 mg/ml Trypsin inhibitor in PBS to inactivate an equal volume of Trypsin. Aspirate cells by pipetting up and down gently (Note: It is important to break down into individual cells as much as possible).
  4. Gently spin down the cells. Wash cells two times with DMEM containing 0.5% FBS to remove trace amounts of trypsin and inhitibor. Resuspend the cells in DMEM with 0.5% FBS and count.
  5. Prepare the transwell compartments, 24-well format, with 8 μm pore size insert:
    1. To the lower compartment, add 2.6 ml of DMEM with 0.5% FBS containing 40 μg ml-1 Collagen I.
    2. Add the transwell insert to the well by merging the bottom of the insert into the medium in the lower compartment.
    Note: Ensure that no air bubbles are trapped between the insert membrane and the medium.
  6. To the upper compartment, gently add 1 x 105 cells from step 4.
  7. Incubate the cells in the transwell plate at 37 °C and 5% CO2 for 2.5 h. This allows cells to migrate toward the underside of the insert filter.
  8. After 2.5 h, carefully take the insert out. Cells that do not migrate through the pores and therefore remain on the upper side of the filter membrane need to be gently removed with a cotton swab. Gently wipe the upper side of the filter membrane with a cotton swab to remove the cell debris. We recommend that use each clean cotton swab for one wipe only, in one direction and do not swipe in back-and-forth movement. The cotton swab can be slightly moisturized with ddH2O as needed but be sure to remove any excess water. Several wipes may be needed to completely remove any cell debris on the membrane.
  9. Fix the cells on the lower side of the insert filter quickly with 5% glutaraldehyde for 10 min.
  10. Next, stain cells on the lower side of the insert filter with 1% crystal violet in 2% ethanol for 20 min.
  11. Remove excess crystal violet by quickly merging the insert in ddH2O for 3 to 4 sec. Drain excess water from the side of the insert using a cotton swab. Dry the insert membrane.
  12. Count the number of cells on the lower side of the filter under a microscope. Randomly choose different views and take average counting.
  13. The same experimental procedure should be performed for control groups without chemoattractants. Each migration condition should be tested with replicates.


This protocol was developed in the Department of Immunology, Scripps Research Institute, La Jolla, CA, USA and adapted from Katoh et al. (2006) and Nakamizo et al. (2005). The work was funded by NIH grants CA079871 and CA114059, and Tobacco-Related Disease, Research Program of the University of California, 15RT-0104 to Dr. Jiing-Dwan Lee  [see Chen et al. (2009)].


  1. Chen, Y., Lu, B., Yang, Q., Fearns, C., Yates, J. R., 3rd and Lee, J. D. (2009). Combined integrin phosphoproteomic analyses and small interfering RNA--based functional screening identify key regulators for cancer cell adhesion and migration. Cancer Res 69(8): 3713-3720.
  2. Katoh, H., Hiramoto, K. and Negishi, M. (2006). Activation of Rac1 by RhoG regulates cell migration. J Cell Sci 119(Pt 1): 56-65.
  3. Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., Chen, J., Hentschel, S., Vecil, G., Dembinski, J., Andreeff, M. and Lang, F. F. (2005). Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65(8): 3307-3318.




  1. 人MDA-MB-231细胞(ATCC,目录号:HTB-26 TM)
  2. Dulbecco's改良的Eagle培养基(DMEM)(Life Technologies,Invitrogen TM,目录号:10313-021)
  3. 胎牛血清(FBS)(ATCC,目录号:30-2020 TM)
  4. 胰蛋白酶-EDTA(Life Technologies,Invitrogen TM,目录号:25200-056)
  5. 胰蛋白酶抑制剂(大豆)(Life Technologies,Invitrogen TM,目录号:17075-029)
  6. 磷酸盐缓冲盐水(PBS)(Life Technologies,Invitrogen TM,目录号:14190-144)
  7. 胶原I(Sigma-Aldrich,目录号:C7661)或纤连蛋白(BD Biosciences,目录号:354008)
  8. 戊二醛(Sigma-Aldrich,目录号:G6257)
  9. 乙醇(Sigma-Aldrich,目录号:459836)
  10. 结晶紫(Sigma-Aldrich,目录号:C3886)
  11. TCC配制的Leibovitz's L-15培养基(ATCC,目录号:30-2008 TM)


  1. (Sigma-Aldrich,目录号:CLS3421)或Millicell细胞培养插入器(EMD Millipore,目录号:PI8P01250)的缓冲液中。
  2. 棉签
  3. 细胞培养孵育器:37℃和5%CO 2/h


  1. 携带MB-231细胞在含10%FBS的DMEM中(如果需要,使用L-15培养基)
  2. 用1x PBS洗涤细胞两次并胰蛋白酶消化
  3. 在PBS中加入0.5mg/ml胰蛋白酶抑制剂以灭活等体积的胰蛋白酶。 通过轻轻地上下吸液吸取细胞(注意:尽可能细分为单个细胞是非常重要的)。
  4. 轻轻地旋转细胞。 用含有0.5%FBS的DMEM洗涤细胞两次,以除去痕量的胰蛋白酶和抑制剂。 重悬细胞在含有0.5%FBS的DMEM中并计数
  5. 准备transwell隔室,24孔格式,具有8μm孔径插入:
    1. 向下部室加入2.6ml含有40μg/ml胶原I的0.5%FBS的DMEM。
    2. 通过将插入物的底部合并到下室中的培养基中,将孔中的插入物添加到孔中。
  6. 到上隔室,轻轻加入来自步骤4的1×10 5个细胞
  7. 孵育transwell板中的细胞在37℃和5%CO 2下2.5小时。这允许细胞迁移到插入过滤器的下侧。
  8. 2.5小时后,小心取出插件。不通过孔迁移并因此保留在滤膜上侧的细胞需要用棉签轻轻去除。用棉签轻轻擦拭滤膜的上侧,以除去细胞碎片。我们建议仅使用每个干净的棉签进行一次擦拭,在一个方向上,不要在前后运动中滑动。根据需要,棉签可以用ddH 2 O轻微润湿,但必须除去任何过量的水。可能需要几次擦拭以完全去除膜上的任何细胞碎片
  9. 用5%戊二醛快速固定插入过滤器下侧的细胞10分钟
  10. 接下来,用1%结晶紫在2%乙醇中的插入过滤器下侧的染色细胞20分钟
  11. 通过快速合并ddH <2> O中的插入物3至4秒除去过量的结晶紫。使用棉签从插件的侧面排出多余的水。干燥插入膜。
  12. 在显微镜下计数过滤器下侧的细胞数。随机选择不同的视图并进行平均计数。
  13. 应该对没有化学引诱物的对照组进行相同的实验程序。每个迁移条件都应该用重复测试。


该方案在美国加利福尼亚州La Jolla的Scripps研究所的免疫学部开发,并改编自Katoh等人。 (2006)和Nakamizo等人(2005)。该工作由NIH资助,CA079871和CA114059,以及加利福尼亚大学的烟草相关疾病研究计划,15RT-0104给Jiing-Dwan Lee博士[见Chen等人]。 (2009)]。


  1. Chen,Y.,Lu,B.,Yang,Q.,Fearns,C.,Yates,J.R.,3rd和Lee,J.D。(2009)。 组合整合素磷蛋白分析和基于小干扰RNA的功能筛选确定了癌细胞粘附的关键调节因子, 。 Cancer Res 69(8):3713-3720。
  2. Katoh,H.,Hiramoto,K。和Negishi,M。(2006)。 RhoG对Rac1的激活调节细胞迁移。 111(Pt 1):56-65。
  3. Nankamizo,A.,Marini,F.,Amano,T.,Khan,A.,Studeny,M.,Gumin,J.,Chen,J.,Hentschel,S.,Vecil,G.,Dembinski, Andreeff,M。和Lang,FF(2005)。 人骨髓间充质干细胞在治疗胶质瘤中的应用 Cancer Res 65(8):3307-3318。
  • English
  • 中文翻译
免责声明 × 为了向广大用户提供经翻译的内容,www.bio-protocol.org 采用人工翻译与计算机翻译结合的技术翻译了本文章。基于计算机的翻译质量再高,也不及 100% 的人工翻译的质量。为此,我们始终建议用户参考原始英文版本。 Bio-protocol., LLC对翻译版本的准确性不承担任何责任。
Copyright: © 2012 The Authors; exclusive licensee Bio-protocol LLC.
引用:Chen, Y. (2012). Transwell Cell Migration Assay Using Human Breast Epithelial Cancer Cell. Bio-protocol 2(4): e99. DOI: 10.21769/BioProtoc.99.

(提问前,请先登录)bio-protocol作为媒介平台,会将您的问题转发给作者,并将作者的回复发送至您的邮箱(在bio-protocol注册时所用的邮箱)。为了作者与用户间沟通流畅(作者能准确理解您所遇到的问题并给与正确的建议),我们鼓励用户用图片或者视频的形式来说明遇到的问题。由于本平台用Youtube储存、播放视频,作者需要google 账户来上传视频。


Young-Sang Kim
PuKyong National University
Hello, I performed transwell migration assay with HT29 cells.
when I take pictures, for counting cells, I cannot distinguish the cells and pores(see the picture).
So, I need help for staining and washing and how to take a picture using microscope.
Other papaers with same experiment, their figures are very clear, when i read papers.
please Help me.
1/28/2016 11:55:46 PM Reply
7/31/2014 9:54:42 PM Reply
xl w
shanghai chempartner
Hi, is the membrane is permeable to collagen? If so, the concentration of collagen will equilibrate between the up and low compartment. How collagen can still work as chemattractants?
Thank you!
2/19/2014 4:04:46 AM Reply
Yanling Chen
The Scripps Research Institute

This experimental setup allows gradient of chemoattractant be established, which is the "driving force" for migration. We don't know how long it takes to "equilibrate" if that would happen eventually, time is also a determining factor here, I think.

2/21/2014 8:29:57 AM

Lisha Chen
Hi, I would like to know why the collagen I were added in the medium in the lower compartment. I saw some experimental procedures say the uupper chambers should be pre-coated with rat collagen type I.What's the function of the rat tail collagen I in this assay? Thank you!
7/2/2013 10:56:38 PM Reply
Yanling Chen
The Scripps Research Institute

Collagen is added as a chemoattractant; you may use other chemoattractants of your choice.

7/19/2013 7:03:50 AM

Lisha Chen

Thank you!I have another question. Is the 2% ethanol in crystal violet solution necessary? If I use the solution that crystal violet dissovled in ddH2O, can it work?

8/13/2013 1:18:07 AM

Yanling Chen
The Scripps Research Institute

I guess that should work too as long as you can get it dissolved well.

8/13/2013 7:30:49 AM

It would be really helpful if you could be more specific about the volume in which we need to dispense the cell in each insert . Just cell number does not help. Also what will be the volume of agonist in the lower chamber and cell in upper chamber in a 96 well plate?
10/16/2012 4:01:16 AM Reply
Hi there,

I have few questions regarding this essay. First, MDA231 cells in my hand didn't migrate to the centre of the insert. After migration (24 h), I saw lot of cells at the rim of the insert. I tried to change the way i added cells, volume of media and cell numbers in the insert. But still none of these worked. I always used 10 % FBS as the chemoattractant (I used comoplete media for this). My first try was ok. Cells migrated evenly through the membrane. But after that I could not get the same result.
Could you please suggest me what would be the problem here?

Many thanks
10/9/2012 8:20:21 PM Reply
Yanling Chen
The Scripps Research Institute

1. Please make sure that the bottom of the insert, when immersed in medium, has no small bubbles trapped underneath (especially the middle area). The microporous membrane should be soaked evenly in medium.
2. Please add the volumes of media/cell according to manufacturer's manual, which keeps the inside/outside media at certain levels.
3. Avoid swirling medium when adding cells to the insert.
4. The transwell plate should be kept steady when incubated, reduce moving it around or shaking it.
5. For your experiments, you may also way to try different cell seeding densities, and/or a shorter migration time.
Hope these can help.

10/17/2012 9:34:08 PM

Will MDA-MB-231 cells migrate/invade with FBS and not EGF? I have read several papers that imply this cell line will not invade/migrate without it. Thanks!
1/24/2012 6:14:35 AM Reply
Yanling Chen
The Scripps Research Institute

In the author's hands, EGF has never been required for successful migration assay using MB231 cells. Some researchers even carry out this assay using medium without either FBS or EGF. Please see reference: PLoS One. 2010 Dec 30;5(12):e15940.

1/28/2012 6:07:03 PM